Various gas plasmas were used to modify biomedical polymers (polyurethane and silicone) to examine the effect changes in hydrophilicity–surface functionality would have on bacterial adhesion and antibiotic retention. X-ray photoelectron spectroscopy (XPS) was used to characterise the modifications. Such treatments could reduce device-related infection on medical devices. While changes in hydrophilicty, as noted by changes in the contact angle, were seen for the various gas plasma (CO 2, H 2O and NH 3), these had little effect upon bacterial adhesion or antibiotic retention. An improvement was noted for antibiotic retention (ciprofloxacin) on the H 2O-plasma treated polyurethane, attributable to the presence of –OH groups, however, this was small. These results suggest that other approaches for reducing device-related infection be examined, such as the direct attachment of a drug-delivery system. To accomplish this for the drug-delivery system of choice, which utilises diisocynate chemistry, the introduction of primary amine groups onto the surface is required. Radiofrequency (RF) and remote microwave (MW) systems were used to introduce these groups onto both the biomedical polymer directly, and an intermediate, ethylene-based, plasma deposited film. The use of such a film would allow this technology to be applied to a variety of different substrates as well as provide a solvent barrier and a means of surface stabilisation. The MW system was found to be superior over the RF system in terms of deposition rate of the polymeric film, the effectiveness of its barrier properties and for the introduction of a higher proportion of primary amine functionality onto the surfaces as determined by XPS. Finally, use of a model system, in conjunction with XPS, confirmed the ability of these modified surfaces to be further derivatised using the isocyanate chemistry associated with the drug-delivery system. The results indicate that electron spectroscopy and surface modification techniques play an important and critical role towards the development of antimicrobial coatings for medical devices.